REGENERX BIOPHARMACEUTICALS INC Contracts & Agreements

Letter to Stockholders dated July 10, 2023 (Filed With SEC on July 10, 2023)

Form of Convertible Promissory Note (Filed With SEC on June 21, 2023)

Form of Warrant to Purchase Common Stock (Filed With SEC on June 21, 2023)

Securities Purchase Agreement between the Company and various investors dated June 28, 2021 (Filed With SEC on August 6, 2021)

Registration Rights Agreement between the Company and various investors dated June 28, 2021 (Filed With SEC on August 6, 2021)

Form of Series A Common Stock Purchase Warrant dated June 30, 2021 (Filed With SEC on August 6, 2021)

Form of Series B Common Stock Purchase Warrant dated June 30, 2021 (Filed With SEC on August 6, 2021)

Lock-Up Agreement between Company and various investors dated June 30, 2021 (Filed With SEC on August 6, 2021)

Form of Convertible Note Purchase Agreement October 2020 (Filed With SEC on November 13, 2020)

Form of Convertible Promissory Note October 2020 (Filed With SEC on November 13, 2020)

Form of Common Stock Warrant October 2020 (Filed With SEC on November 13, 2020)

Amendment N. 1 to License Agreement dated February 25, 2019 between the Company and Lees Pharmaceutical (HK) Limited (Filed With SEC on November 14, 2019)

Amendment No. 1 to RGN-259 License Agreement (PAN ASIA) dated September 17, 2019 between Company and GtreeBNT Co., Ltd (Filed With SEC on November 14, 2019)

Form of Convertible Note Purchase Agreement February 2019 (Filed With SEC on May 15, 2019)

Form of Convertible Promissory Note February 2019 (Filed With SEC on May 15, 2019)

Form of Common Stock Warrant February 2019 (Filed With SEC on May 15, 2019)

2018 Equity Incentive Plan (Filed With SEC on March 29, 2019)

Warrant Reprice Agreement between the Company and the Purchasers identified therein dated March 2, 2018 (Filed With SEC on March 29, 2018)

Form of Common Stock Warrant (Filed With SEC on March 29, 2018)

Amendment No. 2, dated as of August 28, 2017, RGN-137 License Agreement between the Company and GTreeBNT Co., LTD, dated March 7, 2014 (Filed With SEC on November 14, 2017)

COMMON STOCK PURCHASE WARRANT RegeneRxBiopharmaceuticals, Inc. (Filed With SEC on July 1, 2016)

PLACEMENT AGENT WARRANT RegeneRxBiopharmaceuticals, Inc. (Filed With SEC on July 1, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 1, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 1, 2016)

JOINT VENTURE AGREEMENT (Filed With SEC on May 15, 2015)

RGN-259 U.S. LICENSEAgreement (Filed With SEC on May 15, 2015)

FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 9, 2014)

ExecutiveEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2014)

SECURITIES PURCHASE AGREEMENT Dated as of March 7, 2014 Between REGENERX BIOPHARMACEUTICALS, INC. and DIGITAL ARIA CO., LTD. (Filed With SEC on May 15, 2014)

RGN-259LICENSE Agreement (Filed With SEC on May 15, 2014)

rgn-137LICENSE Agreement (Filed With SEC on May 15, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 9, 2014)

REGENERX BIOPHARMACEUTICALS, INC. ______________________________ CONVERTIBLE NOTE PURCHASE AGREEMENT January 7, 2014 (Filed With SEC on January 9, 2014)

RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 9, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 17, 2013)

REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on September 17, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 11, 2013)

REGENERX BIOPHARMACEUTICALS, INC. ______________________________ CONVERTIBLE NOTE PURCHASE AGREEMENT July 5, 2013 (Filed With SEC on July 11, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 3, 2013)

REGENERX BIOPHARMACEUTICALS, INC. ______________________________ CONVERTIBLE NOTE PURCHASE AGREEMENT March 29, 2013 (Filed With SEC on April 3, 2013)

RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on January 8, 2013)

LICENSEAgreement (Filed With SEC on November 14, 2012)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 24, 2012)

REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 24, 2012)

REGENERX BIOPHARMACEUTICALS, INC. ______________________________ CONVERTIBLE NOTE AND WARRANT PURCHASEAGREEMENT OCTOBER 19,2012 (Filed With SEC on October 24, 2012)

RegeneRxBiopharmaceuticals, Inc. · 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### · FAX ###-###-#### · WEB www.regenerx.com (Filed With SEC on August 14, 2012)

RegeneRxBiopharmaceuticals, Inc. ·15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### ·FAX ###-###-#### ·WEB www.regenerx.com (Filed With SEC on August 14, 2012)

Amendedand Restated Change in Control Agreement (Filed With SEC on August 14, 2012)

LEES PHARMACEUTICAL (HK) LIMITED/REGENERX BIOPHARMACEUTICALS, INC. PROPOSED LICENSING TRANSACTION BINDING TERM SHEET *HIGHLY CONFIDENTIAL* March 16, 2012 (Filed With SEC on May 15, 2012)

RegeneRxBiopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on May 15, 2012)

AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 15, 2012)

RegeneRx Biopharmaceuticals,Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 PHONE301 ###-###-#### FAX ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)

RegeneRx Biopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470, Rockville, MD20850 PHONE ###-###-#### FAX301 ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on January 6, 2012)

RegeneRx Biopharmaceuticals, Inc 15245 Shady Grove Road, Suite 470, Rockville, MD20850 PHONE ###-###-#### FAX301 ###-###-#### WEB www.regenerx.com (Filed With SEC on January 6, 2012)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on January 6, 2012)

SECOND AMENDMENT TO THE SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 6, 2011)

FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 6, 2011)

SECOND AMENDMENT TO THE SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 6, 2011)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 7, 2011)

Void After January 7, 2016 (Filed With SEC on January 7, 2011)

REGENERX BIOPHARMACEUTICALS, INC. OMNIBUS WARRANT AMENDMENT AGREEMENT (Filed With SEC on January 7, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 7, 2011)

PURCHASE AGREEMENT (Filed With SEC on January 7, 2011)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 7, 2011)

REGENERX BIOPHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT JANUARY 5, 2011 (Filed With SEC on January 7, 2011)

REGENERX BIOPHARMACEUTICALS, INC. ____________________ SECURITIES PURCHASE AGREEMENT JANUARY 5, 2011 (Filed With SEC on January 7, 2011)

RegeneRx Biopharmaceuticals, Inc. 2010 Equity Incentive Plan Adopted by the Board of Directors Effective as of & Approved by the Stockholders: July 14, 2010 Termination Date: July... (Filed With SEC on July 20, 2010)

RegeneRx Biopharmaceuticals, Inc. Stock Option Grant Notice (2010 Equity Incentive Plan) (Filed With SEC on July 20, 2010)

11,500,000 UNITS (Filed With SEC on May 21, 2010)

WARRANT AGREEMENT (Filed With SEC on May 21, 2010)

REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on May 21, 2010)

[] UNITS (Filed With SEC on May 17, 2010)

WARRANT AGREEMENT (Filed With SEC on May 17, 2010)

SUBSCRIPTION FORM To Be Executed by the Registered Holder in Order to Exercise Warrants (Filed With SEC on May 17, 2010)

REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on May 17, 2010)

TEN COM as tenants in common UNIF GIFT MIN ACT- _________Custodian _________TEN ENT as tenants by the entireties (Cust) (Minor)JT TEN as joint tenants with right of under Uniform... (Filed With SEC on April 16, 2010)

Form of Right Certificate (Filed With SEC on April 16, 2010)

RIGHTS AGREEMENT (Filed With SEC on April 16, 2010)

AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on April 16, 2010)

RGN-137, a topically applied gel for chronic dermal wounds and reduction of scar tissue (Filed With SEC on March 31, 2010)

REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 5, 2009)

REGENERX BIOPHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT SEPTEMBER 30, 2009 (Filed With SEC on October 5, 2009)

PLACEMENT AGENCY AGREEMENT September 30, 2009 (Filed With SEC on September 30, 2009)

COMMON STOCK PURCHASE WARRANT REGENERX BIOPHARMACEUTICALS, INC. Warrant Shares: _____ Initial Exercise Date: _____, 2009 (Filed With SEC on September 30, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 30, 2009)

REGENERX BIOPHARMACEUTICALS, INC. (Filed With SEC on April 16, 2009)

REGENERX BIOPHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT APRIL 13, 2009 (Filed With SEC on April 16, 2009)

RGN-137, a topically applied gel for hard-to-heal chronic dermal wounds (Filed With SEC on April 15, 2009)

REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 12, 2008)

REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 27, 2008)

Amendment No. 1 to Employment Agreement By and between RegeneRx Biopharmaceuticals, Inc. and C. Neil Lyons Dated April 12, 2007 (Filed With SEC on December 21, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2007)

REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 18, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 18, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 18, 2006)

REGENERX BIOPHARMACEUTICALS, INC. Amended and Restated 2000 Stock Option and Incentive Plan (Filed With SEC on August 14, 2006)

FORM OF WARRANT REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK Warrant No.: ____________ Number of Shares: ___________ Issuance Date: March __, 2006 (Filed With SEC on March 7, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 7, 2006)

FORM OF WARRANT (Filed With SEC on January 6, 2005)

WARRANT (Filed With SEC on January 6, 2005)

Category

Industry

Companies

Contracts

REGENERX BIOPHARMACEUTICALS INC Contracts & Agreements